Engineered heart tissues formed with cardiac progenitors and differentiated cardiomyocytes exhibit similar physiologic properties at differentiation-matched timepoints
Open Access
- 1 October 2025
- journal article
- Published by IOP Publishing in Biofabrication
- Vol. 17 (4) , 045023
Abstract
Congenital heart diseases, including single ventricle heart defects such as hypoplastic left and right heart syndromes, remain a leading cause of neonatal death and long-term morbidity. Regenerative medicine approaches hold great therapeutic promise for treating single ventricle disease, specifically through the use of human pluripotent stem cell-derived cardiomyocytes (iPSC-CM) to generate pulsatile conduits capable of growing and developing over time within the recipient. However, current strategies for rapidly fabricating large-scale engineered heart muscle to create such conduits face limitations, including the shear stress generated during most bioprinting processes along with harsh enzymatic treatments required for initial singularization of cells prior to bioprinting, which together can compromise cell viability and downstream tissue function. Here, we explored the use of derived cardiovascular progenitors (iPSC-CVP) as an alternative to fully differentiated cardiomyocytes as a potential cell source for future biomanufacturing efforts. We demonstrate that iPSC-CVP can be used to form functional engineered heart tissues with similar electrophysiological properties to tissues formed from fully differentiated iPSC-CM, while also being more amenable to enzymatic dissociation and mechanical manipulation. Our results suggest that iPSC-CVP may be an ideal cell population for future efforts in biofabrication of contractile structures such as engineered heart muscle and pulsatile conduits.Keywords
Funding Information
- Washington University in St. Louis
- University of Pittsburgh
- Sarnoff Cardiovascular Research Foundation
- Dr. Michael Vahey
- American Heart Association (19CDA34730016)
- Additional Ventures Cures Collaborative
- Burroughs Welcome
- National Heart, Lung, and Blood Institute (R01HL159094)
This publication has 59 references indexed in Scilit:
- Enhancing human pluripotent stem cell differentiation to cardiomyocytes through cardiac progenitor reseeding and cryopreservationiScience, 2025
- Dual human iPSC-derived cardiac lineage cell-seeding extracellular matrix patches promote regeneration and long-term repair of infarcted heartsBioactive Materials, 2023
- High-throughput longitudinal electrophysiology screening of mature chamber-specific hiPSC-CMs using optical mappingiScience, 2023
- Large‐Scale Production of Wholly Cellular Bioinks via the Optimization of Human Induced Pluripotent Stem Cell Aggregate Culture in Automated BioreactorsAdvanced Healthcare Materials, 2022
- iPSC-Derived Micro-Heart Muscle for Medium-Throughput Pharmacology and Pharmacogenomic Studies2022
- Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytesActa Biomaterialia, 2020
- Epigenetic Priming of Human Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Accelerates Cardiomyocyte MaturationStem Cells, 2019
- Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem CellsCurrent Protocols in Human Genetics, 2015
- Three-dimensional filamentous human diseased cardiac tissue modelBiomaterials, 2014
- A Temporal Chromatin Signature in Human Embryonic Stem Cells Identifies Regulators of Cardiac DevelopmentCell, 2012